Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine

This publication has 148 references indexed in Scilit:

• Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
  Nature, 2011
• Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
  Science Translational Medicine, 2011
• Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
  Genes & Development, 2010
• Rapid-Response Splicing Reporter Screens Identify Differential Regulators of Constitutive and Alternative Splicing
  Molecular and Cellular Biology, 2010
• RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
  Nature Biotechnology, 2010
• Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
  Nature Biotechnology, 2008
• Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy
  Human Molecular Genetics, 2008
• Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition
  Human Molecular Genetics, 2008
• Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
  The American Journal of Human Genetics, 2008
• Rare Missense and Synonymous Variants in UBE1 Are Associated with X-Linked Infantile Spinal Muscular Atrophy
  The American Journal of Human Genetics, 2008